Alcohol dependence frequently co-occurs with cigarette smoking, another common addictive behavior. Evidence from genetic studies demonstrates that alcohol dependence and smoking cluster in families and have shared genetic vulnerability. Recently a candidate gene study in nicotine dependent cases and nondependent smoking controls reported strong associations between a missense mutation (rs16969968) in exon 5 of the CHRNA5 gene and a variant in the 3 0 -UTR of the CHRNA3 gene and nicotine dependence. In this study we performed a comprehensive association analysis of the CHRNA5-CHRNA3-CHRNB4 gene cluster in the Collaborative Study on the Genetics of Alcoholism (COGA) families to investigate the role of genetic variants in risk for alcohol dependence. Using the family-based association test, we observed that a different group of polymorphisms, spanning CHRNA5-CHRNA3, demonstrate association with alcohol dependence defined by Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV) criteria. Using logistic regression we replicated this finding in an independent case-control series from the family study of cocaine dependence. These variants show low linkage disequilibrium with the SNPs previously reported to be associated with nicotine dependence and therefore represent an independent observation. Functional studies in human brain reveal that the variants associated with alcohol dependence are also associated with altered steady-state levels of CHRNA5 mRNA. Molecular Psychiatry (2009) 14, 501-510; doi:10.1038/mp.2008 published online 15 April 2008 Keywords: nicotinic acetylcholine receptors; mRNA expression; alcohol dependence; polymorphism
Introduction
It is well established that alcohol and tobacco use are highly correlated in humans. Current smokers are more likely to drink heavily and to binge drink than those who have never smoked, and alcoholics smoke more heavily and endorse nicotine withdrawal symptoms at a higher rate than nonalcoholics. [1] [2] [3] [4] [5] The National Longitudinal Epidemiologic Survey reported that early onset smoking was a significant predictor of lifetime drinking and subsequent progression to lifetime alcohol abuse and dependence. 6 Both alcohol dependence and habitual smoking are transmitted in families and genetic factors contribute to the development of both of these disorders. [7] [8] [9] [10] [11] [12] [13] [14] Evidence from electrophysiological, pharmacological and neurochemical studies suggest that ethanol may interact with nicotinic acetylcholine receptors (nAChR). [15] [16] [17] [18] The nAChR gene family has 11 known subunits (a 2 , a 3 , a 4 , a 5 , a 6 , a 7 , a 8 , a 9 and b 2 , b 3 , b 4 ); these subunits form pentameric receptors with different combinations of subunits. 19, 20 The effects of ethanol on nAChRs depend on the receptor subunit composition. Studies using different nAChR subtype compositions expressed in Xenopus oocytes demonstrate that ethanol tends to increase nicotine responsiveness in a2b2, a3b2 and a4b2 receptor subtypes, whereas low concentrations of ethanol inhibit homomeric a7-receptor function. 16, 21 Ethanol also modulates nAChR potentiation. The combinations of a2b4 and a4b2 are the most sensitive receptors to potentiation by ethanol. The a4b4 and a2b2 combinations are slightly less sensitive and the a3b2 and a3b4 combinations are insensitive to ethanol. 16 Several genetic association studies involving addiction in humans have focused on the genes encoding the major nAChR subunits expressed in the brain (a4 and b2). A family-based study in human populations reported genetic variants in CHRNA4 and CHRNB2 that are significantly associated with a protective effect against nicotine addiction. 22 The involvement of CHRNA4, but not CHRNB2, in nicotine addiction was confirmed in another familybased study. 23 A population-based study among ethnically diverse young adults reported that a polymorphism located immediately upstream of CHRNB2 was associated with initial subjective response to both alcohol and tobacco. 24 Recently a comprehensive genome-wide association study and a candidate gene study using nicotine dependent smokers as cases and nondependent smokers as controls demonstrated significant association between several genetic variants in nicotine receptors and nicotine dependence. 25, 26 As CHRNA5, CHRNA3 and CHRNB4 genes cluster together on chromosome 15q, we performed a comprehensive association analysis with this gene cluster in the families of the Collaborative Study on the Genetics of Alcoholism (COGA) to investigate the role of genetic variants in these three nAChRs in risk for alcohol dependence. We also confirmed our findings in an independent dataset.
Materials and methods

Study subjects
Alcohol-dependent probands, defined by meeting lifetime criteria for both Diagnostic and Statistical Manual of Mental Disorders, 3rd ed (DSM-IIIR) alcohol dependence 27 and Feighner criteria for definite alcoholism 28 were systematically recruited from alcohol-treatment units. Families in which two additional first-degree relatives also met lifetime criteria for alcohol dependence were invited to participate in the genetic protocol. A total of 262 families including 2309 individuals were selected for the genetic study and an average of 4.6 alcohol-dependent individuals per pedigree were genotyped; 29, 30 (http://www.niaaagenetics. org/coga_instruments/resources.html). Among these pedigrees, 298 individuals from 35 pedigrees are of African-American descent and 8 pedigrees are of mixed ancestry (by self-report).
All subjects were assessed using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA). 31, 32 Affected individuals were those who were alcohol dependent by DSM-IV criteria. Unaffected individuals were those who drank but had no more than two DSM-IV symptoms of alcohol dependence and were not dependent on any illicit substance. When multiple interviews were available, we required consistency in all interviews for affected/ unaffected status.
Genotyping assays dbSNP (http://www.ncbi.nlm.nih.gov/SNP/) was used to identify polymorphisms within and flanking the genes encoding CHRNA5, CHRNA3 and CHRNB4 on the long arm of chromosome 15. We used Sequenom MassArray technology (http://www.sequenom.com), homogenous MassEXTEND (hME) or iPLEX assays for genotyping of single nucleotide polymorphisms (SNPs). PCR primers, termination mixes and multiplexing capabilities were determined with Sequenom MassARRAY Assay Designer software v3.1.2.2. Standard procedures were used to amplify PCR products; unincorporated nucleotides were deactivated with shrimp alkaline phosphatase. A primer extension reaction was then carried out with the mass extension primer and the appropriate termination mix (hME) or terminator (iPLEX). The primer extension products were then cleaned with resin and spotted onto a silicon SpectroChip. The chip was scanned with a mass spectrometry workstation (Bruker), and the resulting genotype spectra were analyzed with the Sequenom SpectroTYPER software v3.4. Call rates greater than 90% and HWE P-value > 0.05 were set as quality control measures. For the 22-bp insertion/deletion (indel) polymorphism (rs3841324), PCR primers (primer sequences available on request) were selected using the MacVector 6.5.3 program (Accelrys) to yield a 166-bp or 188-bp genomic fragment containing the indel. The nonsynonymous coding SNP in exon 5, rs16969968, originally identified by sequencing 40 individuals from COGA families, was genotyped using an RFLP assay with TaqaI restriction enzyme. Genotypes for rs3841324 and rs16969968 were detected by electrophoresis on a 2% agarose gel.
Statistical analyses
Linkage disequilibrium (LD) between markers was computed using the program Haploview. 33 The family-based association test (FBAT) 34, 35 was used to examine association between the variants and alcohol dependence, defined by DSM-IV criteria. FBAT builds on the original time domain transmission (TDT) method 36 in which alleles transmitted to affected offspring are compared with the expected distribution of alleles among offspring. In particular, the method puts tests of different genetic models, tests of different sampling designs, tests involving different disease phenotypes, tests with missing parents and tests of different null hypotheses all into the same framework. Similar in spirit to a classical TDT test, the approach compares the genotype distribution observed in the cases to its expected distribution under the null hypothesis, with the null hypothesis being no linkage and no association, or no association in the presence of linkage. Here, the expected distribution is derived using Mendel's law of segregation and conditioned on the sufficient statistics for any nuisance parameters under the null. Because conditioning eliminates all nuisance parameters, the technique avoids confounding due to model misspecification as well as admixture or population stratification. 37, 38 The data shown in Table 1 are from the standard FBAT analysis with age and gender as covariates. To correct for multiple testing we used false discovery rate (FDR) with a default threshold of 0.05. 39 Replication study with the family study of cocaine dependence data set Study subjects. Unrelated cases and matched unrelated controls within the candidate-gene study of the family study of cocaine dependence (FSCD) were used for this study. 40 Cocaine dependent subjects were recruited from publicly and privately funded inpatient and outpatient chemical dependency treatment centers in the St Louis area. Eligibility requirements included meeting DSM-IV criteria for cocaine dependence, being 18 years of age or older, speaking fluent English and having a full sibling within five years of their age who was willing to participate in the family arm of the study. Control subjects were recruited through driver's license records maintained by the Missouri Family Registry at Washington University in St Louis for research purposes. Controls were matched to cocaine dependent subjects based on age, ethnicity, gender and zip code. Control subjects were not dependent on alcohol or drugs, including nicotine, but did use at least alcohol because non-substance using individuals are considered phenotypically unknown. The project was approved by the Washington University IRB and all subjects provided informed consent. All participants completed a modified version of the SSAGA. 31, 32 Genotyping assays. Genotyping for the FSCD study was conducted by the Center for Inherited Disease Research (CIDR) using a custom SNP array on an Illumina platform. Details of genotyping procedures are available at the CIDR website (http://www. cidr.jhmi.edu/index.html). Additional genotyping was performed by Sequenom assays described above.
Statistical analysis. LD between markers was computed using the program COCAPHASE. 41 We used logistic regression 42 to examine the association between the SNPs and DSM-IV alcohol dependence. For analysis, we selected those cases who were comorbid for DSM-IV alcohol and cocaine dependence and compared them with all of the study controls. This subset included 451 unrelated individuals of European-American descent (207 alcohol-dependent cases and 244 controls) and 424 unrelated individuals of African-American descent (185 alcohol-dependent cases and 239 controls). Separate logistic regression models were run for the European and African-American subjects as well as a combined analysis that incorporated all samples and included race as a covariate and a genotype by race interaction term. Three logistic regression models were examined for each variant to test for additive effects and evidence of dominant or recessive modes of inheritance. The additive effect of a SNP was modeled using an ordinal measure of the number of copies of the risk allele. The dominant and recessive effects of a SNP were modeled using dichotomous indicator variables. For each variant, the model with the strongest association with DSM-IV alcohol dependence, based on the adjusted odds ratio and the magnitude of the corresponding P-value, is reported in Table 2 . Genomic DNA from all subjects was genotyped for the SNP, rs588765, which exhibits the lowest P-value in the African-American population. The polymorphism, rs3841324 was also genotyped because of its location within the promoter of the CHRNA5 gene. Gene expression levels were analyzed by real-time PCR using an ABI-7500 real-time PCR system. A TaqMan assay (Hs00181248_m1, ABI) was used for quantifying the expression level of CHRNA5 in the frontal cortex. The expression levels of CHRNA3 were determined in cerebellum using a TaqMan assay (Hs00609519, ABI) due to the low expression levels of CHRNA3 in frontal cortex. Primers and a TaqMan probe (sequences available on request) for the reference gene, GAPDH were designed over exon-exon boundaries using the Primer Express 3 (ABI) program. Each real-time PCR run included within-plate duplicates and each experiment was performed twice for each sample. Correction for sample-to-sample variation was done by simultaneously amplifying GAPDH as a reference. Real-time data were analyzed using the comparative C t method. 43 The C t values of each sample were normalized with the C t value for the housekeeping gene, GADPH and were corrected for the PCR efficiency of each assay, 43 although the efficiency of all reactions was close to 100%. Only the samples with an s.e. < 0.15 were analyzed. We used the nonparametric Mann-Whitney U-statistic to test for evidence of differential expression in samples of different genotypes.
Results
Forty-one single nucleotide polymorphisms (SNPs)
and an indel within and flanking this cluster of nAChRs were genotyped (Figure 1a) . Each of the polymorphisms was in Hardy-Weinberg equilibrium in the founders. Three SNPs that had a minor allele frequency (MAF) less than 5% were removed from the analyses. Using pair-wise linkage disequilibrium analysis, we observed three groups of highly correlated variants tagged by three putative functional polymorphisms, a 22 bp indel (rs3841324) in the promoter region of the CHRNA5 gene, a missense mutation (rs16969968) in exon 5 of the CHRNA5 gene, and a SNP (rs578776) in the 3 0 -UTR of the CHRNA3 gene, respectively ( Figure 1a ; Table 1 ).
Genetic variants in the CHRNA5-CHRNA3-CHRNB4 gene cluster are associated with alcohol dependence in the COGA data set Eight variants spanning 52 kb in the CHRNA5-CHRNA3-CHRNB4 gene cluster were significantly associated with alcohol dependence using FBAT analysis adjusted for age and gender ( Table 1) . Seven of these variants are highly correlated (r 2 X0.7, Figure 1b ). These associated polymorphisms include rs1979906 in the region upstream of the CHRNA5 gene, a 22 bp indel (rs3841324) in the promoter region of CHRNA5, four intronic SNPs in the CHRNA5 gene and one intronic SNP in the CHRNA3 gene ( Figure 1a ; Table 1 ). The eighth SNP (rs1051730), a synonymous variant in exon 5 of the CHRNA3 gene has a lesser degree of linkage disequilibrium (r 2 p0.4). To determine whether this association was driven by nicotine dependence, we also analyzed the association with habitual smoking as a covariate and found that the association of these polymorphisms with alcohol dependence is independent of smoking status. These polymorphisms remain significant after adjusting for multiple testing using the FDR. 39 In contrast, we observed no association between alcohol dependence and either of the SNPs previously reported to be associated with nicotine dependence: the missense mutation (rs16969968) in CHRNA5 and rs578776 located within the 3 0 -UTR of CHRNA3. 26, 44 A similar pattern of association was seen for all polymorphisms across the gene cluster in affected only analyses and in analyses without covariates.
Replication of the association with alcohol dependence in an independent data set from the FSCD To further examine the genetic contribution of variants in this gene cluster to risk for alcohol dependence we genotyped 18 polymorphisms showing high linkage disequilibrium with each other (r 2 X0.7 in European Americans), in an independent data set from the FSCD ( Table 2) . Using logistic regression analysis we confirmed the association between each of these SNPs and alcohol dependence in the subjects of European descent. In the AfricanAmerican subset, 10 of the 18 polymorphisms, spanning CHRNA5 and CHRNA3, showed significant association with alcohol dependence. Six of these polymorphisms have a lower MAF in African Americans ( < 0.31 vs 0.4) but slightly higher odds ratios than in the European American sample (Table 2) . To test whether the genetic associations observed show statistically significant differences between the two racial groups we repeated the logistic regression including a genotype by race interaction term. None of the variants showed significant evidence of genetic heterogeneity by race.
Allelic differences in expression of CHRNA5 in human frontal cortex To examine whether the variants associated with alcohol dependence have a direct effect on gene expression, we performed quantitative real-time PCR analysis with human brain tissue from nondemented elderly European Americans. Genomic DNA from all subjects was genotyped for multiple variants in CHRNA5. Genotypes were in Hardy-Weinberg equilibrium. We then examined CHRNA5 mRNA expression with SNP, rs588765 in 13 samples homozygous for the major allele (CC), 9 samples homozygous for the minor allele (TT), and 21 heterozygous samples (CT). Subjects homozygous for the minor allele of rs588765 showed a 2-fold increase (TT = 1.88±1.2; CC = 0.98±1.04; P = 0.025) in CHRNA5 mRNA expression compared to subjects homozygous for the major allele (Figure 2) . Similar results were obtained with rs3841324 (SS = 2.21±1.15; LL = 0.89±0.89; P = 0.02). Heterozygotes for both rs588765 and rs3841324 showed lower expression levels for CHRNA5, compared with homozygotes for the minor allele (P = 0.0003 and P = 0.02 for rs3841324 and rs588765, respectively). However, no significant differences were found between heterozygotes and homozygotes for the major allele (Figure 2) . In contrast CHRNA3 expression in the same individuals showed no association with alleles of rs588765 or rs3841324 (data not shown). This expression data suggest that the functional allele explaining the association with alcohol dependence regulates CHRNA5 expression. However, in these European American samples available for our expression studies we are not able to determine which variant is responsible for the expression differences.
To validate this observation using an independent data set and methodology we tested for association between variability in CHRNA5 mRNA expression in lymphoblastoid cell lines derived from CEPH families using the Affymetrix HG Focus panel (Genetic Analysis Workshop 15; www.gaworkshop.org/gaw15. htm). 45, 46 We retrieved genotypes for rs588765 from the HapMap database and examined the difference in CHRNA5 mRNA expression in subjects with different genotypes at rs588765 in 14 genotyped trios. Using SOLAR VC quantitative analysis of the CHRNA5 mRNA levels with additive genetic effects, we detected significant differences in expression in subjects of different genotypes (P = 0.02). This SNP accounted for approximately 14% of the variance in CHRNA5 gene expression in this system.
Discussion
Alcohol dependence frequently co-occurs with tobacco use. Evidence from electrophysiological and neurochemical studies suggest that ethanol and nicotine share important mechanisms of action in the brain reward pathways and nAChRs. 17 A study using the COGA data set demonstrated that the clinical characteristics of alcohol use history are associated with smoking status; current smokers and nicotine-dependent subjects had a greater severity of alcohol dependence. 3 Although the main nAChRs in the brain are believed to contain a4 and b2 subunits, a recent comprehensive candidate gene study implicated SNPs in the genes encoding the a3, a5, and b3 subunits, including a missense mutation, rs16969968, in the CHRNA5 gene as risk factors for nicotine dependence. 26 Given the shared genetic vulnerability for nicotine and alcohol dependence, detected through twin studies, 9, 14 we undertook a detailed analysis of the CHRNA5-CHRNA3-CHRNB4 gene cluster in the COGA data set. Although the association between the missense mutation in CHRNA5 and nicotine dependence has been replicated in several data sets, including the COGA data set, 44 we saw no evidence of association between this SNP and alcohol dependence, suggesting that the effect of this polymorphism is specific to nicotine. Similarly, the group of SNPs in linkage disequilibrium with rs578776 shows strong association with nicotine dependence 26 but shows no evidence of association with alcohol dependence in the COGA data set.
In this study we provide replicated evidence of association for 16 correlated variants with alcohol dependence in two data sets of European descent. The strong association detected in the FSCD data set, where all cases are both cocaine dependent and alcohol dependent, raises the possibility that these variants may also be associated with alcohol related phenotypes, such as illicit drug dependence and antisocial personality disorder. With lower levels of LD among the polymorphisms in the African-American population (Table 3) , we observed a narrower region of association extending from rs588765 in intron 1 of CHRNA5 to rs6495307 in intron 5 of CHRNA3. The SNPs showing the lowest P-values in the African-American sample have a MAF of 30% compared to 46% in the European-American sample. As we do not see genetic association with the indel in African Americans, this suggests that further studies should prioritize SNPs in high LD with rs588765. Although there are differences in the LD between the polymorphisms in the European-American and African-American subjects from the FSCD data set, none of these variants demonstrated significant evidence of genetic heterogeneity between the two populations. Thus, though there are some differences in significance and effect sizes between the variants, we cannot definitively determine which polymorphism is causing the functional changes. Using brain mRNA from European Americans we observed an association between the minor alleles of rs588765 and rs3841324 (r 2 = 0.8 in European Americans) and higher levels of CHRNA5 mRNA. . Circles represent a sample homozygous for minor allele (TT) and squares represent a sample homozygous for major allele (CC). The level of expression was calculated from the C t value (the cycle at which the fluorescence intensity rises above a threshold) and was normalized by taking GAPDH as a reference. (b) Mann-Whitney U-statistic, two-tailed analysis of CHRNA5 total expression in subjects with homozygous for the major allele (CC), subjects with homozygous for the minor allele (TT) and heterozygous subjects (CT). y-Axis represents the relative expression level taking an arbitrary reference samples as 1. Mean±s.d. is shown; * indicates P-value < 0.05.
This association with CHRNA5 expression was replicated in the GAW15 data set with rs588765. 45, 46 Several in-vitro studies have examined 5 0 regulatory sequences of CHRNA5. [47] [48] [49] Functional characterization of CHRNA5 using luciferase assays in human cell lines has previously demonstrated that the À240/ þ 53 region, which contains the rs3841324 indel, is the core promoter. 47, 48 A second study has directly tested the effect of the indel using a standardized reporter gene assay system and reported that it alters promoter activity in HEK293t cells by 1.5-fold. 49 However, our genetic data in African Americans does not support a primary role of this polymorphism in influencing CHRNA5 expression in the brain. No in-vitro functional experiments have been performed using other putative regulatory regions of CHRNA5. Further examination on CHRNA5 mRNA expression in African-American subjects may be very helpful in narrowing down the likely functional variant because of the lower levels of LD across CHRNA5 in this population.
In the mammalian brain, nAChRs include homopentameric a7 receptors and a variety of heteropentamers, but predominantly a4b2*, where the asterisk denotes the presence of another subunit. In many brain areas, the a5 polypeptide completes the a4b2* complex, with stoichiometry a4 2 b2 2 a5.
20,50,51
The a5 subunit contributes one-fifth of the channel lining and therefore can influence channel properties. 20 Studies using heterologous expression systems have demonstrated that addition of the a5 subunit has profound effects on the functional properties of a3b4 receptors.
52 CHRNA5 increases the rate of desensitization of a3b4 receptors as well as the Ca 2 þ permeability and decreases the efficacy of nicotine on a3b4 nAchRs.
In conclusion, we provide replicated evidence of association between multiple polymorphisms within the CHRNA5 and CHRNA3 genes and alcohol dependence. Furthermore, we demonstrate that the minor alleles of these polymorphisms are associated with higher CHRNA5 mRNA levels in human frontal cortex. These results suggest that although variation in CHRNA5 influences risk for both alcohol dependence and nicotine dependence, different polymorphisms and different mechanisms of action are responsible for these effects on risk. 
